Published in BMC Infect Dis on November 06, 2012
Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties. AIDS Res Hum Retroviruses (2013) 1.04
Sustained High HIV Incidence in Young Women in Southern Africa: Social, Behavioral, and Structural Factors and Emerging Intervention Approaches. Curr HIV/AIDS Rep (2015) 0.97
Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy. Rev Med Virol (2016) 0.91
Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches. Curr HIV/AIDS Rep (2014) 0.86
The Art of HIV Elimination: Past and Present Science. J AIDS Clin Res (2015) 0.82
Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection. J Antimicrob Chemother (2014) 0.81
Pregnancy incidence and risk factors among women participating in vaginal microbicide trials for HIV prevention: systematic review and meta-analysis. PLoS One (2013) 0.80
Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide. BMC Infect Dis (2016) 0.75
HIV prevention and research considerations for women in sub-Saharan Africa: moving toward biobehavioral prevention strategies. Afr J Reprod Health (2014) 0.75
A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models. PLoS One (2015) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (2002) 11.02
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 7.93
Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA (1992) 6.99
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Violence against women: global scope and magnitude. Lancet (2002) 6.42
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med (2008) 6.00
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86
A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med (1998) 4.35
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet (2010) 3.90
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One (2008) 3.45
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS (2011) 2.86
Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. Annu Rev Med (2008) 2.81
Progress and obstacles in the development of an AIDS vaccine. Nat Rev Immunol (2006) 2.72
SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS One (2007) 2.41
Vaginal microbicides and the prevention of HIV transmission. Lancet Infect Dis (2008) 2.25
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS One (2008) 2.09
Female-controlled methods to prevent sexual transmission of HIV. AIDS (1996) 2.09
Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet (1992) 2.08
Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial. JAMA (2002) 1.98
Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis. A comparative clinical trial. JAMA (1987) 1.75
A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis (1988) 1.55
Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis (2001) 1.50
A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol (1990) 1.39
Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Res (2009) 1.30
Male circumcision for prevention of homosexual acquisition of HIV in men. Cochrane Database Syst Rev (2011) 1.16
The future of HIV microbicides: challenges and opportunities. Antivir Chem Chemother (2009) 1.13
Microbicides in the prevention of HIV infection: current status and future directions. Drugs (2010) 0.95
Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patients. Clin Diagn Lab Immunol (2002) 0.91
A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe. Contraception (2007) 0.91
Topical microbicides for prevention of sexually transmitted infections. Cochrane Database Syst Rev (2012) 0.87
Vaginal microbicides for preventing mother-to-child transmission of HIV infection--no evidence of an effect or evidence of no effect? S Afr Med J (2007) 0.79
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet (2013) 8.18
Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health (2007) 3.68
Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lancet (2008) 3.28
Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol (2008) 3.19
Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods (2004) 2.50
Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med (2012) 2.32
Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol (2008) 2.27
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol (2010) 2.25
Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. J Infect Dis (2011) 2.24
Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis. PLoS One (2012) 2.09
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis (2008) 2.05
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med (2010) 2.03
Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis (2007) 1.72
Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy. Int J Infect Dis (2008) 1.66
The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis (2006) 1.64
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infect Dis (2013) 1.57
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine (2009) 1.45
The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One (2011) 1.42
Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response. J Immunol (2006) 1.40
Association between fertility and HIV status: what implications for HIV estimates? BMC Public Health (2008) 1.38
Strengthening the expanded programme on immunization in Africa: looking beyond 2015. PLoS Med (2013) 1.32
A prospective, cross-sectional study of anaemia and peripheral iron status in antiretroviral naïve, HIV-1 infected children in Cape Town, South Africa. BMC Infect Dis (2002) 1.32
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults. Am J Respir Crit Care Med (2013) 1.31
Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis (2009) 1.28
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews. BMC Public Health (2012) 1.20
Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis. BMC Med (2009) 1.14
HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. J Infect Dis (2009) 1.12
'Communicate to vaccinate' (COMMVAC). building evidence for improving communication about childhood vaccinations in low- and middle-income countries: protocol for a programme of research. Implement Sci (2011) 1.12
A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. Am J Respir Crit Care Med (2012) 1.09
Wealth and sexual behaviour among men in Cameroon. BMC Int Health Hum Rights (2006) 1.05
"Communicate to vaccinate": the development of a taxonomy of communication interventions to improve routine childhood vaccination. BMC Int Health Hum Rights (2013) 1.04
Improved measles surveillance in Cameroon reveals two major dynamic patterns of incidence. Int J Infect Dis (2005) 1.04
Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease. Vaccine (2010) 1.03
Global health: the importance of evidence-based medicine. BMC Med (2013) 1.02
Growth and micronutrient disturbances in stable, HIV-infected children in Cape Town. Ann Trop Paediatr (2002) 1.01
The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr Infect Dis J (2006) 0.99
Immunotherapy for tuberculous pericarditis. N Engl J Med (2014) 0.97
Too little, too late: measles epidemic in South Africa. Lancet (2010) 0.96
Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome. Pediatr Infect Dis J (2004) 0.94
A bibliometric analysis of childhood immunization research productivity in Africa since the onset of the Expanded Program on Immunization in 1974. BMC Med (2013) 0.94
Making BCG vaccination programmes safer in the HIV era. Lancet (2008) 0.90
Factors that affect the uptake of community-based health insurance in low-income and middle-income countries: a systematic protocol. BMJ Open (2014) 0.89
Citation classics in systematic reviews and meta-analyses: who wrote the top 100 most cited articles? PLoS One (2013) 0.89
Review of rotavirus studies in Africa: 1976-2006. J Infect Dis (2010) 0.89
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol. Syst Rev (2013) 0.89
Understanding interventions for improving routine immunization coverage in children in low- and middle-income countries: a systematic review protocol. Syst Rev (2013) 0.89
Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa. J Paediatr Child Health (2007) 0.88
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol. BMJ Open (2014) 0.88
Incidence and Diagnosis of Pertussis in South African Children Hospitalized With Lower Respiratory Tract Infection. Pediatr Infect Dis J (2016) 0.88
HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study. PLoS One (2008) 0.87
Topical microbicides for prevention of sexually transmitted infections. Cochrane Database Syst Rev (2012) 0.87
Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. Clin Immunol (2008) 0.87
The impact of mass media interventions on tuberculosis awareness, health-seeking behaviour and health service utilisation: a systematic review protocol. BMJ Open (2014) 0.85
Developing vaccinology expertise for Africa: six years and counting. Vaccine (2011) 0.84
The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative. Pan Afr Med J (2011) 0.83
Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin. Pediatr Infect Dis J (2002) 0.83
Contemporary use of adjunctive corticosteroids in tuberculous pericarditis. Int J Cardiol (2007) 0.81
Lessons and myths in the HIV/AIDS response. Lancet (2009) 0.81
A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease. Expert Rev Hematol (2015) 0.80
Trends in the types and quality of childhood immunisations research output from Africa 1970-2010: mapping the evidence base. BMC Health Serv Res (2014) 0.80
Chronic Chlamydia pneumoniae infection and stroke in Cameroon: a case-control study. Stroke (2006) 0.79
HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load. AIDS Res Hum Retroviruses (2011) 0.77
Antiviral efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV-infected children and adolescents: a systematic review protocol. Syst Rev (2014) 0.77
Use of systematic reviews in WHO recommendations. Lancet (2011) 0.77
Ovarian stimulation, egg aspiration, in vitro fertilization and embryo transfer in the baboon (Papio anubis): a pilot project at the Institute of Primate Research, Nairobi, Kenya. Gynecol Obstet Invest (2004) 0.76
Public stewardship of private for-profit healthcare providers in low- and middle-income countries. Cochrane Database Syst Rev (2016) 0.75
Interventions for improving coverage of childhood immunisation in low- and middle-income countries. Cochrane Database Syst Rev (2016) 0.75
Misoprostol and pregnancy termination. Lancet (2007) 0.75
Knowledge, attitudes and practices on adolescent vaccination among parents, teachers and adolescents in Africa: a systematic review protocol. Syst Rev (2014) 0.75
Safety of licensed vaccines in HIV-infected persons: a systematic review protocol. Syst Rev (2014) 0.75
The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children. Pediatr Infect Dis J (2015) 0.75
Atrial fibrillation as a consequence of tuberculous pericardial effusion. Int J Cardiol (2012) 0.75
Delivery arrangements for health systems in low-income countries: an overview of systematic reviews. Cochrane Database Syst Rev (2017) 0.75
Cochrane Column. Int J Epidemiol (2016) 0.75
Implementation strategies for health systems in low-income countries: an overview of systematic reviews. Cochrane Database Syst Rev (2017) 0.75
Governance arrangements for health systems in low-income countries: an overview of systematic reviews. Cochrane Database Syst Rev (2017) 0.75
SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosis. S Afr Med J (2012) 0.75